{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T03:24:24Z","timestamp":1648956264172},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1999,8,1]],"date-time":"1999-08-01T00:00:00Z","timestamp":933465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[1999,8]]},"DOI":"10.1053\/gast.1999.0029900492","type":"journal-article","created":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T13:58:00Z","timestamp":1122645480000},"page":"492-495","source":"Crossref","is-referenced-by-count":5,"title":["Methotrexate in the treatment of primary biliary cirrhosis: The hype and the hope"],"prefix":"10.1053","volume":"117","author":[{"given":"Paul","family":"Angulo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.Rolland","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/gast.1999.0029900492_BIB1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1089-3261(05)70011-8","article-title":"Management of primary biliary cirrhosis and autoimmune cholangitis","volume":"2","author":"Angulo","year":"1998","journal-title":"Clin Liver Dis"},{"key":"10.1053\/gast.1999.0029900492_BIB2","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199405123301903","article-title":"Ursodiol for the treatment of primary biliary cirrhosis","volume":"330","author":"Poupon","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/gast.1999.0029900492_BIB3","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1053\/gast.1996.v110.pm8613058","article-title":"Effects of ursodeoxycholic acid on survival of patients with primary biliary cirrhosis","volume":"1110","author":"Lindor","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.1999.0029900492_BIB4","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.1999.0029900492_BIB5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.510290301","article-title":"Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis","volume":"29","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/gast.1999.0029900492_BIB6","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0016-5085(91)90085-Y","article-title":"Treatment of primary biliary cirrhosis with low-dose weekly methotrexate","volume":"101","author":"Kaplan","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.1999.0029900492_BIB7","doi-asserted-by":"crossref","first-page":"124A","DOI":"10.1016\/0270-9139(95)94219-X","article-title":"Methotrexate therapy of primary biliary cirrhosis: 2 yr study comparing two doses (abstr)","volume":"22","author":"Conjeevaram","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/gast.1999.0029900492_BIB8","first-page":"295","article-title":"Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis","volume":"91","author":"Bergasa","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/gast.1999.0029900492_BIB9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-126-9-199705010-00002","article-title":"Sustained biochemical and histologic remission of primary bilair y cirrhosis in response to medical treatment","volume":"126","author":"Kaplan","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1053\/gast.1999.0029900492_BIB10","doi-asserted-by":"crossref","first-page":"176A","DOI":"10.1016\/0270-9139(93)92232-O","article-title":"Double blind trial of methotrexate (MTX) versus colchicine (COLCH) in primary biliary cirrhosis (PBC) (abstr)","volume":"18","author":"Kaplan","year":"1993","journal-title":"Hepatology"},{"key":"10.1053\/gast.1999.0029900492_BIB11","first-page":"152A","article-title":"Methotrexate improves histology in primary biliary cirrhosis (PBC) (abstr)","volume":"20","author":"Kaplan","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/gast.1999.0029900492_BIB12","first-page":"342","article-title":"The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis","volume":"122","author":"Bach","year":"1998","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/gast.1999.0029900492_BIB13","first-page":"545A","article-title":"Methotrexate therapy for primary biliary cirrhosis: five year follow-up (abstr)","volume":"28","author":"Bach","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/gast.1999.0029900492_BIB14","first-page":"A1406","article-title":"Methotrexate therapy in primary biliary cirrhosis is of limited efficacy and accompanied by serious side effects (abstr)","volume":"112","author":"Vandeputte","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.1999.0029900492_BIB15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0016-5085(94)90085-X","article-title":"Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis","volume":"107","author":"Sharma","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.1999.0029900492_BIB16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0168-8278(97)80294-2","article-title":"The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone","volume":"27","author":"Gonzalez-Koch","year":"1997","journal-title":"J Hepatol"},{"key":"10.1053\/gast.1999.0029900492_BIB17","first-page":"1158","article-title":"The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study","volume":"22","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/gast.1999.0029900492_BIB18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/gast.1999.0029900400","article-title":"Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial","volume":"117","author":"Hendrickse","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.1999.0029900492_BIB19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/gast.1999.0029900395","article-title":"Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol","volume":"117","author":"Bonis","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.1999.0029900492_BIB20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198301063080101","article-title":"The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis","volume":"308","author":"Roll","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1053\/gast.1999.0029900492_BIB21","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/0016-5085(85)90213-6","article-title":"Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis: final results of an international trial","volume":"89","author":"Christensen","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.1999.0029900492_BIB22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"key":"10.1053\/gast.1999.0029900492_BIB23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/00365529009107932","article-title":"Factors of prognostic importance in primary biliary cirrhosis","volume":"25","author":"Rydning","year":"1990","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/gast.1999.0029900492_BIB24","first-page":"713","article-title":"Risk factors and prognosis in primary biliary cirrhosis [published erratum appears in Am J Gastroenterol 1989;84:1474]","volume":"84","author":"Goudie","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/gast.1999.0029900492_BIB25","first-page":"955","article-title":"Natural history and prognostic variables in primary biliary cirrhosis (PBC) (abstr)","volume":"12","author":"Jeffrey","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/gast.1999.0029900492_BIB26","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.1840100516","article-title":"Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability","volume":"10","author":"Grambsch","year":"1989","journal-title":"Hepatology"},{"key":"10.1053\/gast.1999.0029900492_BIB27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","volume":"1","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"key":"10.1053\/gast.1999.0029900492_BIB28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of non-suppurative cholangitis (syndrome of primary biliary cirrhosis)","volume":"329","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A"},{"key":"10.1053\/gast.1999.0029900492_BIB29","first-page":"392A","article-title":"Absence of pulmonary toxicity in primary biliary cirrhosis (PBC) treated with methotrexate and ursodiol (abstr)","volume":"28","author":"Munoz","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/gast.1999.0029900492_BIB30","first-page":"909","article-title":"Controlled trial of high and low dose d-penicillamine (DP) in primary biliary cirrhosis (PBC): results at three years (abstr)","volume":"23","author":"Bassendine","year":"1982","journal-title":"Gut"},{"key":"10.1053\/gast.1999.0029900492_BIB31","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM198504183121602","article-title":"Trial of penicillamine in advanced primary biliary cirrhosis","volume":"312","author":"Dickson","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1053\/gast.1999.0029900492_BIB32","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0016-5085(86)90183-6","article-title":"Randomized trial of chlorambucil for primary biliary cirrhosis","volume":"91","author":"Hoofnagle","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.1999.0029900492_BIB33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0016-5085(93)90422-9","article-title":"Cyclosporine A treatment in primary biliary cirrhosis: results of a long-term placebo-controlled trial","volume":"104","author":"Lombard","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.1999.0029900492_BIB34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0016-5085(88)90300-9","article-title":"Evaluation of colchicine therapy in primary biliary cirrhosis","volume":"95","author":"Bodenheimer","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.1999.0029900492_BIB35","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/hep.1840140607","article-title":"Long-term follow up of patients with primary biliary cirrhosis on colchicine therapy","volume":"14","author":"Zifroni","year":"1991","journal-title":"Hepatology"},{"key":"10.1053\/gast.1999.0029900492_BIB36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0168-8278(05)80043-1","article-title":"The results of a randomized double blind trial evaluating malotilate in primary biliary cirrhosis","volume":"17","author":"van Buuren","year":"1993","journal-title":"J Hepatol"},{"key":"10.1053\/gast.1999.0029900492_BIB37","first-page":"759","article-title":"A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"22","author":"Combes","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/gast.1999.0029900492_BIB38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-8278(05)80004-2","article-title":"Positive response to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone","volume":"18","author":"Busher","year":"1993","journal-title":"J Hepatol"},{"key":"10.1053\/gast.1999.0029900492_BIB39","first-page":"84","article-title":"Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis","volume":"44","author":"Wolfhagen","year":"1994","journal-title":"Neth J Med"},{"key":"10.1053\/gast.1999.0029900492_BIB40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0168-8278(96)80191-7","article-title":"Effects of additional administration of colchicine in ursodeoxycholic acid\u2013treated patients with primary biliary cirrhosis: a prospective randomized study","volume":"24","author":"Ikeda","year":"1996","journal-title":"J Hepatol"},{"key":"10.1053\/gast.1999.0029900492_BIB41","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.510240520","article-title":"A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis","volume":"24","author":"Poupon","year":"1996","journal-title":"Hepatology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508599001808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508599001808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T11:00:06Z","timestamp":1552129206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508599001808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,8]]}},"alternative-id":["S0016508599001808"],"URL":"https:\/\/doi.org\/10.1053\/gast.1999.0029900492","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[1999,8]]}}}